Mark Dawson

Cambridge Epigenetix has named Mark Dawson to its scientific advisory board. Dawson is a professor in the Sir Peter MacCallum Department of Oncology and Centre for Cancer Research at the University of Melbourne, where he is the program head of the Translational Haematology Program, group leader of the Cancer Epigenetics Laboratory, and consultant hematologist in the Department of Hematology. His research is focused on epigenetic regulation in normal and malignant hematopoiesis and he is a leading expert on the development of targeted epigenetics-based therapeutics, Cambridge Epigenetix noted.